Literature DB >> 13968615

Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives.

W BOLLAG, E GRUNBERG.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; HYDRAZINES

Mesh：

Substances：

Year:  1963        PMID： 13968615     DOI： 10.1007/BF02171589

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  2 in total

1.  The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide.

Authors:  K BERNEIS; M KOFLER; W BOLLAG; A KAISER; A LANGEMANN
Journal:  Experientia       Date:  1963-03-15

2.  Cytological investigations with a new class of cytotoxic agents. methylhydrazine derivatives.

Authors:  A RUTISHAUSER; W BOLLAG
Journal:  Experientia       Date:  1963-03-15
  2 in total
  19 in total

1.  [EXTENDED SURVIVAL OF SKIN HOMOGRAFTS IN MICE BY A METHYLHYDRAZINE DERIVATIVE].

Authors:  G L FLOERSHEIM
Journal:  Experientia       Date:  1963-10-15

2.  [ON THE METABOLISM OF A CYTOSTATIC METHYLHYDRAZINE DERIVATIVE (NATULAN)].

Authors:  J RAAFLAUB; D E SCHWARTZ
Journal:  Experientia       Date:  1965-01-15

3.  Methylhydrazine derivatives, a new class of cytotoxic agents.

Authors:  P ZELLER; H GUTMANN; B HEGEDUS; A KAISER; A LANGEMANN; M MULLER
Journal:  Experientia       Date:  1963-03-15

4.  The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide.

Authors:  K BERNEIS; M KOFLER; W BOLLAG; A KAISER; A LANGEMANN
Journal:  Experientia       Date:  1963-03-15

5.  Cytological investigations with a new class of cytotoxic agents. methylhydrazine derivatives.

Authors:  A RUTISHAUSER; W BOLLAG
Journal:  Experientia       Date:  1963-03-15

6.  Suppression of the immunological reaction by methylhydrazines, a new class of antitumour agents.

Authors:  W BOLLAG
Journal:  Experientia       Date:  1963-06-15

Review 7.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

8.  [The cytostatic action mechanism of Natulan].

Authors:  G Weitzel; F Schneider; D Kummer; H Ochs
Journal:  Z Krebsforsch       Date:  1968

9.  [The inhibition of nucleic acid synthesis and transplantibility of Ehrlich ascites tumor cells by natulan, trenimon and p-benzoquinone].

Authors:  F Hölzel; E Wulfmeyer; I Schwencke; H Maass
Journal:  Z Krebsforsch       Date:  1967

Review 10.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.